Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

Annals of Surgical Oncology

Volumn 23, Issue 5, 2016, Pages 1474-1480

  Ihemelandu, Chukwuemeka ^a   Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; ANTINEOPLASTIC AGENT;

ADULT; APPENDIX CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; PERITONEUM METASTASIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; SURVIVAL RATE; TUMOR DIFFERENTIATION; ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; APPENDICEAL NEOPLASMS; CANCER STAGING; CARCINOMA, SIGNET RING CELL; FOLLOW UP; INTRAPERITONEAL DRUG ADMINISTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEAL NEOPLASMS; PROGNOSIS; SECONDARY; TUMOR RECURRENCE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APPENDICEAL NEOPLASMS; CARCINOMA, SIGNET RING CELL; COMBINED MODALITY THERAPY; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84947912931     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4995-0     Document Type: Article

References (39)

1. McCusker ME, Cote TR, Clegg LX, et al. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology, and end-results program, 1973–1998. Cancer. 2002;94:3307–12.
2. Nitecki SS, Wolff BG, Schlinkert R, et al. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg. 1994;219:51–7.
3. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population-based study. Eur J Surg Oncol. 2008;34:196–201.
4. Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol. 1995;26:509–24.
5. Carr NJ, Sobin LH. Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO Classification of Tumours of the Digestive System. International Agency for Research on Cancer (IARC), Lyon, 2010, pp 122–5.
6. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei.” Am J Surg Pathol. 1995;19:1390–408.
7. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92:85–91.
8. Didolkar MS, Fanous N. Adenocarcinoma of the appendix: a clinicopathologic study. Dis Colon Rectum. 1977;20:130–4.
9. Chang P, Attiyeh FF. Adenocarcinoma of the appendix. Dis Colon Rectum. 1981;24:176–80.
10. Cortina R, McCormick J, Kolm P, Perry RR. Management and prognosis of adenocarcinoma of the appendix. Dis Colon Rectum. 1995;38:848–52.
11. Cerame MA. A 25-year review of adenocarcinoma of the appendix: a frequently perforating carcinoma. Dis Colon Rectum. 1988;31:145–50.
12. Qizilbash AH. Primary adenocarcinoma of the appendix: a clinicopathological study of 11 cases. Arch Pathol Lab Med. 1975;99:556–62.
13. Butler JA, Houshiar A, Lin F, et al. Goblet cell carcinoid of the appendix. Am J Surg. 1994;168:685–7.
14. Ratzenhofer M, Aubock L. The amphicrine (endo-exocrine) cells in the human gut, with a short reference to amphicrine neoplasias. Acta Morphol Acad Sci Hung. 1980;28:37–58.
15. Warkel RL, Cooper PH, Helwig EB. Adenocarcinoid, a mucin-producing carcinoid tumor of the appendix: a study of 39 cases. Cancer. 1978;42:2781–93.
16. Klein HZ. Mucinous carcinoid tumor of the vermiform appendix. Cancer. 1974;33:770–7.
17. Gallegos NC, Milroy C, Linehan IP, et al. Crypt cell carcinoma of the appendix. Eur J Surg Oncol. 1992;18:386–7.
18. Isaacson P. Crypt cell carcinoma of the appendix (so-called adenocarcinoid tumor). Am J Surg Pathol. 1981;5:213–24.
19. Haqqani MT, Williams G. Mucin-producing carcinoid tumours of the vermiform appendix. J Clin Pathol. 1977;30:473–80.
20. Watson PH, Alguacil-Garcia A. Mixed crypt cell carcinoma: a clinicopathological study of the so-called “goblet cell carcinoid.” Virchows Arch A Pathol Anat Histopathol. 1987;412:175–82.
21. Edmonds P, Merino MJ, LiVolsi VA, Duray PH. Adenocarcinoid (mucinous carcinoid) of the appendix. Gastroenterology. 1984;86:302–9.
22. Sugarbaker PH. Dissection by electrocautery with a ball tip. J Surg Oncol. 1994;56:246–8.
23. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49–58.
24. Sugarbaker PH. An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy. In: Sugarbaker PH (ed) Cytoreductive Surgery and Perioperative Chemotherapy for Peritoneal Surface Malignancy: Textbook and Video Atlas. Cine-Med Publishing, Woodbury, CT, 2012, pp 1–30.
25. Mohamed F, Sugarbaker PH. Intraperitoneal taxanes. Surg Oncol Clin North Am. 2003;12:825–33.
26. Sugarbaker PH. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol. 2005;92:142–6.
27. Sugarbaker P, Bijelic L, Chang et al. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin. J Surg Oncol. 2010;102:576–81.
28. Bijelic L, Kumar A, Stuart A, et al. Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival. Gastroenterol Res Pract. 2012;2012:163284.
29. Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg. 2006;93:783–92.
30. Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2007;15:526–34.
31. Smeenk R, Verwaal V, Antonini N, et al. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104–9.
32. Jimenez W, Sardi A, Nieroda C, et al. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21:4218–25.
33. Glehen O, Mohamed F, Sugarbaker P. Incomplete cytoreduction in 174 patients with periotoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004;240:278–85.
34. Baumgartner J, Tobin L, Heavey S, et al. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22:1716–21.
35. Ko YH, Park SH, Jung CK, et al. Clinical characteristics and prognostic factors for primary appendiceal carcinoma. Asia Pac J Clin Oncol. 2010;6:19–27.
36. Misdraji J, Young RH. Primary epithelial neoplasms and other epithelial lesions of the appendix (excluding carcinoid tumors). Semin Diagn Pathol. 2004;21:120–33.
37. Park IJ, Yu CS, Kim HC, et al. Clinical features and prognostic factors in primary adenocarcinoma of the appendix. Korean J Gastroenterol. 2004;43:29–34.
38. McGory ML, Maggard MA, Kang H, et al. Malignancies of the appendix: beyond case series reports. Dis Colon Rectum. 2005;48:2264–71.
39. Turaga K, Pappas S, Gamblin C. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379–85.